PTPL1, a proapoptotic protein tyrosine phosphatase in breast cancers;PTPL1, une protéine tyrosine phosphatase proapoptotique dans les cancers mammaires

Bulletin du Cancer

Volumn 91, Issue 4, 2004, Pages 325-332

  Freiss, Gilles ^a   Bompard, Guillaume ^b   Vignon, Françoise ^a  

^a INSERM   (France)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Apoptosis; Mammary cancer; PTPL1; Tyrosine phosphatase

Indexed keywords

ANTIESTROGEN; PROTEIN KINASE B; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE L1; TUMOR MARKER; UNCLASSIFIED DRUG;

APOPTOSIS; BREAST CANCER; CELL DIFFERENTIATION; CELL TRANSFORMATION; CELLULAR DISTRIBUTION; HUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; REVIEW; TISSUE SPECIFICITY; TUMOR CELL;

BREAST NEOPLASMS; CELL SURVIVAL; CYTOSKELETON; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PROTEIN-TYROSINE-PHOSPHATASE; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL;

EID: 2442667548     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Tonks NK, Neel BG. From form to function : signaling by protein tyrosine phosphatases. Cell 1996 ; 87 : 365-8.
2. Hennipman A, van Oirschot BA, Smits J, Rijksen G, Staal GE. Tyrosine kinase activity in breast cancer, benign breast disease, and normal breast tissue. Cancer Res 1989 ; 49 : 516-21.
3. Ottenhoff-Kalff AE, van Oirschot BA, Hennipman A, de Weger RA, Staal GE, Rijksen G. Protein tyrosine phosphatase activity as a diagnostic parameter in breast cancer. Breast Cancer Res Treat 1995 ; 33 : 245-56.
4. Den Hertog J, Pals CE, Peppelenbosch MP, Tertoolen LG, de Laat SW, Kruijer W. Receptor protein tyrosine phosphatase alpha activates pp60c-src and is involved in neuronal differentiation. EMBO J 1993 ; 12 : 3789-98.
5. Sieh M, Bolen JB, Weiss A. CD45 specifically modulates binding of Lck to a phosphopeptide encompassing the negative regulatory tyrosine of Lck. EMBO J 1993 ; 12 : 315-21.
6. Kmiecik TE, Shalloway D. Activation and suppression of pp60c-src transforming ability by mutation of its primary sites of tyrosine phosphorylation. Cell 1987 ; 49 : 65-73.
7. Ronnstrand L, Arvidsson AK, Kallin A, Rorsman C, Hellman U, Engstrom U, et al. SHP-2 binds to Tyr763 and Tyr1009 in the PDGF beta-receptor and mediates PDGF-induced activation of the Ras/MAP kinase pathway and chemotaxis. Oncogene 1999 ; 18 : 3696-702.
8. Chen H, Wertheimer SJ, Lin CH, Katz SL, Amrein KE, Burn P, Quon MJ. Protein-tyrosine phosphatases PTP1B and syp are modulators of insulin-stimulated translocation of GLUT4 in transfected rat adipose cells. J Biol Chem 1997 ; 272 : 8026-31.
9. Tiganis T, Kemp BE, Tonks NK. The protein-tyrosine phosphatase TCPTP regulates epidermal growth factor receptor-mediated and phosphatidylinositol 3-kinase-dependent signaling. J Biol Chem 1999 ; 274 : 27768-75.
10. Jiao H, Berrada K, Yang W, Tabrizi M, Platanias LC, Yi T. Direct association with and dephosphorylation of Jak2 kinase by the SH2-domain-containing protein tyrosine phosphatase SHP-1. Mol Cell Biol 1996 ; 16 : 6985-92.
11. Sun H, Charles CH, Lau LF, Tonks NK. MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell 1993 ; 75 : 487-93.
12. Thangaraju M, Sharma K, Leber B, Andrews DW, Shen SH, Srikant CB. Regulation of acidification and apoptosis by SHP-1 and Bcl-2. J Biol Chem 1999 ; 274 : 29549-57.
13. Keane MM, Lowrey GA, Ettenberg SA, Dayton MA, Lipkowitz S. The protein tyrosine phosphatase DEP-1 is induced during differentiation and inhibits growth of breast cancer cells. Cancer Res 1996 ; 56 : 4236-43.
14. Palka HL, Park M, Tonks NK. Hepatocyte growth factor receptor tyrosine kinase met is a substrate of the receptor protein-tyrosine phosphatase DEP-1. J Biol Chem 2003 ; 278 : 5728-35.
15. Freiss G, Prebois C, Vignon F, William L. McGuire Memorial Symposium. Control of breast cancer cell growth by steroids and growth factors : interactions and mechanisms. Breast Cancer Res Treat 1993 ; 27 : 57-68.
16. Yarden Y, Ullrich A. Growth factor receptor tyrosine kinases. Annu Rev Biochem 1988 ; 57 : 443-78.
17. Freiss G, Vignon F. Antiestrogens increase protein tyrosine phosphatase activity in human breast cancer cells. Mol Endocrinol 1994 ; 8 : 1389-96.
18. Freiss G, Puech C, Vignon F. Extinction of insulin-like growth factor-I mitogenic signaling by antiestrogen-stimulated Fas-associated protein tyrosine phosphatase-1 in human breast cancer cells. Mol Endocrinol 1998 ; 12 : 568-79.
19. Banville D, Ahmad S, Stocco R, Shen SH. A novel protein-tyrosine phosphatase with homology to both the cytoskeletal proteins of the band 4.1 family and junction-associated guanylate kinases. J Biol Chem 1994 ; 269 : 22320-7.
20. Maekawa K, Imagawa N, Nagamatsu M, Harada S. Molecular cloning of a novel protein-tyrosine phosphatase containing a membrane-binding domain and GLGF repeats. FEBS Lett 1994 ; 337 : 200-6.
21. Saras J, Claesson-Welsh L, Heldin CH, Gonez LJ. Cloning and characterization of PTPL1, a protein tyrosine phosphatase with similarities to cytoskeletal-associated proteins. J Biol Chem 1994 ; 269 : 24082-9.
22. Sato T, Irie S, Kitada S, Reed J.C. FAP-1 : a protein tyrosine phosphatase that associates with Fas. Science 1995 ; 268 : 411-5.
23. Inazawa J, Ariyama T, Abe T, Dtuck T, Ohta M, Huebner K, et al. T. PTPN13, a Fas-associated protein tyrosine phosphatase, is located on the long arm of chromosome 4 at band q21.3. Genomics 1996 ; 31 : 240-2.
24. Harris BZ, Lim WA. Mechanism and role of PDZ domains in signaling complex assembly. J Cell Sci 2001 ; 114 : 3219-31.
25. Christopherson KS, Hillier BJ, Lim WA, Bredt DS. PSD-95 assembles a ternary complex with the N-methyl-D-aspartic acid receptor and a bivalent neuronal NO synthase PDZ domain. J Biol Chem 1999 ; 274 : 27467-73.
26. Cuppen E, Gerrits H, Pepers B, Wieringa B, Hendriks W. PDZ motifs in PTP-BL and RIL bind to internal protein segments in the LIM domain protein RIL. Mol Biol Cell 1998 ; 9 : 671-83.
27. Maekawa K, Imagawa N, Naito A, Harada S, Yoshie O, Takagi S. Association of protein-tyrosine phosphatase PTP-BAS with the transcription-factor-inhibitory protein IkappaBalpha through interaction between the PDZ1 domain and ankyrin repeats. Biochem J 1999 ; 337 : 179-84.
28. Lee SH, Shin MS, Park WS, Kim SY, Kim HS, Lee JH, et al. Immunohistochemical localization of FAP-1, an inhibitor of Fas-mediated apoptosis, in normal and neoplastic human tissues. APMIS 1999 ; 107 : 1101-8.
29. Saras J, Engstrom U, Gonez LJ, Heldin CH. Characterization of the interactions between PDZ domains of the protein-tyrosine phosphatase PTPL1 and the carboxyl-terminal tail of Fas. J Biol Chem 1997 ; 272 : 20979-81.
30. Ivanov VN, Lopez BP, Maulit G, Sato TA, Sassoon D, Ronai Z. FAP-1 association with Fas (Apo-1) inhibits Fas expression on the cell surface. Mol Cell Biol 2003 ; 23 : 3623-35.
31. Cuppen E, Nagata S, Wieringa B, Hendriks W. No evidence for involvement of mouse protein-tyrosine phosphatase-BAS-like Fas-associated phosphatase-1 in Fas-mediated apoptosis. J Biol Chem 1997 ; 272 : 30215-20.
32. Palmer A, Zimmer M, Erdmann KS, Eulenburg V, Porthin A, Heumann R, et al. EphrinB phosphorylation and reverse signaling : regulation by Src kinases and PTP-BL phosphatase. Mol Cell 2002 ; 9 : 725-37.
33. Erdmann KS, Kuhlmann J, Lessmann V, Herrmann L, Eulenburg V, Muller O, et al. The adenomatous polyposis coli-protein (APC) interacts with the protein tyrosine phosphatase PTP-BL via an alternatively spliced PDZ domain. Oncogene 2000 ; 19 : 3894-901.
34. Gross C, Heumann R, Erdmann KS. The protein kinase C-related kinase PRK2 interacts with the protein tyrosine phosphatase PTP-BL via a novel PDZ domain binding motif. FEBS Lett 2001 ; 496 : 101-4.
35. Saras J, Franzen P, Aspensttom P, Hellman U, Gonez LJ, Heldin CH. A novel GTPase-activating protein for Rho interacts with a PDZ domain of the protein-tyrosine phosphatase PTPL1. J Biol Chem 1997 ; 272 : 24333-8.
36. Cuppen E, van Ham M, Wansink DG, de Leeuw A, Wieringa B, Hendriks W. The zyxin-related protein TRIP6 interacts with PDZ motifs in the adaptor protein RIL and the protein tyrosine phosphatase PTP-BL. Eur J Cell Biol 2000 ; 79 : 283-93.
37. Murthy KK, Clark K, Fortin Y, Shen SH, Banville D. ZRP-1, a zyxin-telated protein, interacts with the second PDZ domain of the cytosolic protein tyrosine phosphatase hPTP1E. J Biol Chem 1999 ; 274 : 20679-87.
38. Hoffman LM, Nix DA, Benson B, Boot-Hanford R, Gustafsson E, Jamora C, et al. Targeted disruption of the murine zyxin gene. Mol Cell Biol 2003 ; 23 : 70-9.
39. Cuppen E, Wijers M, Schepens J, Fransen J, Wieringa B, Hendriks W. A FERM domain governs apical confinement of PTP-BL in epithelial cells. J Cell Sci 1999 ; 112 : 3299-308.
40. Bompard G, Martin M, Roy C, Vignon F, Freiss G. Membrane targeting of protein tyrosine phosphatase PTPL1 through its FERM domain via binding to phosphatidylinositol 4,5-biphosphate. J Cell Sci 2003 ; 116 : 2519-30.
41. Martin M, Roy C, Montcourrier P, Sahuquet A, Mangeat P. Three determinants in ezrin are responsible for cell extension activity. Mol Biol Cell 1997 ; 8 : 1543-57.
42. Mangeat P, Roy C, Martin M. ERM proteins in cell adhesion and membrane dynamics. Trends Cell Biol 1999 ; 9 : 187-92.
43. Kimber WA, Deak M, Prescott AR, Alessi DR. Interaction of the protein tyrosine phosphatase PTPL1 with the PtdIns(3,4)P 2 binding adaptor protein TAPP1. Biochem J 2003 ; 376 : 525-35.
44. Herrmann L, Dittmar T, Erdmann KS. The protein tyrosine phosphatase PTP-BL associates with the midbody and is involved in the regulation of cytokinesis. Mol Biol Cell 2003 ; 14 : 230-40.
45. Bompard G, Puech C, Prebois C, Vignon F, Freiss G. Protein-tyrosine phosphatase PTPL1/FAP-1 triggers apoptosis in human breast cancer cells. J Biol Chem 2002 ; 277 : 47861-9.
46. Bardon S, Vignon F, Montcourrier P, Rochefort H. Steroid receptor-mediated cytotoxicity of an antiestrogen and an antiprogestin in breast cancer cells. Cancer Res 1987 ; 47 : 1441-8.
47. Resnicoff M, Baserga R. The role of the insulin-like growth factor I receptor in transformation and apoptosis. Ann N Y Acad Sci 1998 ; 842 : 76-81 : 76-81.
48. Werner H, Le Roith D. The insulin-like growth factor-I receptor signaling pathways are important for tumorigenesis and inhibition of apoptosis. Cr Rev Oncog 1997 ; 8 : 71-92.